GLP 1 News and Research

RSS
Poll: Vast majority of older adults think health insurers should cover obesity medications

Poll: Vast majority of older adults think health insurers should cover obesity medications

Tirzepatide shows success in maintaining weight loss in obese adults

Tirzepatide shows success in maintaining weight loss in obese adults

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Second-line diabetes drugs safe for babies? New study offers reassurance

Second-line diabetes drugs safe for babies? New study offers reassurance

Study explores the intricate gut-brain-liver connection and its impact on health

Study explores the intricate gut-brain-liver connection and its impact on health

A class of diabetes medications may reduce the risk of colorectal cancer

A class of diabetes medications may reduce the risk of colorectal cancer

Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

The role of the brainstem in appetite suppression

The role of the brainstem in appetite suppression

New insights into the brain's control of eating speed

New insights into the brain's control of eating speed

Single injection of novel hydrogel could replace weekly diabetes injections

Single injection of novel hydrogel could replace weekly diabetes injections

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Study highlights safety concerns of SGLT2i in patients with diabetes and cancer

Study highlights safety concerns of SGLT2i in patients with diabetes and cancer

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show zesty promise in type 2 diabetes management

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.